Mostrando 1 - 5 resultados de 5 para a busca 'Maja Hinge', tempo de busca: 0.02s Refinar Resultados
  1. 1
    Baseline bone involvement in multiple myeloma – a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients

    Baseline bone involvement in multiple myeloma – a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography... por Maja Hinge, Kristian T. Andersen, Thomas Lund, Henrik B. Jørgensen, Paw C. Holdgaard, Tina E. Ormstrup, Lone L. Østergaard, Torben Plesner

    Publicado em 2016-10-01
    Obter o texto integral
    Artigo
  2. 2
    Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment

    Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment por Maja Hinge, Kristian T Andersen, Thomas Lund, Henrik B Jørgensen, Paw C Holdgaard, Tina E Ormstrup, Lone L Østergaard, Torben Plesner

    Publicado em 2016-10-01
    Obter o texto integral
    Artigo
  3. 3
    Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma

    Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly D... por Kristian T. Andersen, Maja Hinge, Agoston Gyula Szabo, Erik Segel, Tina Ormstrup, Paw C. Holdgaard, Niels Pallisgaard, Gitte Kerndrup, Torben Plesner

    Publicado em 2020-01-01
    Obter o texto integral
    Artigo
  4. 4
    P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

    P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA por Christian Brieghel, Morten Nørgaard Andersen, Nicolai Grønne Jørgensen, Trine Silkjær, Thomas Lund, Maja Hinge, Henrik Gregersen, Robert Schou Pedersen, Agoston Szabo, Carsten Niemann

    Publicado em 2023-08-01
    Obter o texto integral
    Artigo
  5. 5
    Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

    Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a... por Lene Kongsgaard Nielsen, Claudia Stege, Birgit Lissenberg-Witte, Bronno van der Holt, Ulf-Henrik Mellqvist, Morten Salomo, Gerard Bos, Mark-David Levin, Heleen Visser-Wisselaar, Markus Hansson, Annette van der Velden, Wendy Deenik, Juleon Coenen, Maja Hinge, Saskia Klein, Bea Tanis, Damian Szatkowski, Rolf Brouwer, Matthijs Westerman, Rineke Leys, Harm Sinnige, Einar Haukås, Klaas van der Hem, Marc Durian, Peter Gimsing, Niels van de Donk, Pieter Sonneveld, Anders Waage, Niels Abildgaard, Sonja Zweegman

    Publicado em 2020-06-01
    Obter o texto integral
    Artigo

Ferramentas de busca: